Bhat Anjali, Yadav Joni, Thakur Kulbhushan, Aggarwal Nikita, Tripathi Tanya, Chhokar Arun, Singh Tejveer, Jadli Mohit, Bharti Alok Chandra
Molecular Oncology Laboratory, Department of Zoology, University of Delhi (North Campus), Delhi, 110007, India.
Cancer Cell Int. 2021 Jun 24;21(1):319. doi: 10.1186/s12935-021-02026-3.
Angiogenic switch is a hallmark feature of transition from low-grade to high-grade cervical intraepithelial neoplasia (CIN) in cervical cancer progression. Therefore, early events leading to locally-advanced cervical metastatic lesions demand a greater understanding of the underlying mechanisms. Recent leads indicate the role of tumor-derived exosomes in altering the functions of endothelial cells in cervical cancer, which needs further investigation.
Exosomes isolated from cervical cancer cell lines were assessed for their angiogenic effect on the human umbilical vein endothelial cells (HUVEC) using tube formation and wound healing assay. The exosomal uptake by HUVEC cells was monitored using PKH-67 labelling followed by fluorescence microscopy. Alterations in Hh-GLI signaling components, PTCH1 and GLI1, in HUVEC were measured by immunoblotting. Changes in angiogenesis-related transcripts of vascular endothelial growth factor VEGF-A, VEGF-B, VEGFR2 and angiopoietin-1, angiopoietin-2, osteopontin were measured in exosome-treated HUVEC and in the exosomal RNA by RT-PCR.
Enhanced tube formation, with an increased number of nodes and branching was observed in HUVEC's treated with exosomes derived from different cervical cancer cell lines. HPV-positive (SiHa and HeLa) cells' exosomes were more angiogenic. Exosome-treated HUVEC showed increased migration rate. PKH-67 labelled exosomes were found internalized in HUVEC. A high level of PTCH1 protein was detected in the exosome-treated endothelial cells. Subsequent RT-PCR analysis showed increased transcripts of Hh-GLI downstream target genes VEGF-A, VEGFR2, angiopoietin-2, and decreased expression of VEGF-B, and angiopoietin-1, suggestive of active Hh-GLI signaling. These effects were more pronounced in HUVEC's treated with exosomes of HPV-positive cells. However, these effects were independent of tumor-derived VEGF-A as exosomal cargo lacked VEGF-A transcripts or proteins.
Overall, the data showed cervical cancer exosomes promote pro-angiogenic response in endothelial cells via upregulation of Hh-GLI signaling and modulate downstream angiogenesis-related target genes. The study provides a novel exosome-mediated mechanism potentially favoring cervical angiogenesis and thus identifies the exosomes as potential pharmacological targets against locally-advanced metastatic cervical lesions.
血管生成开关是宫颈癌进展过程中从低级别宫颈上皮内瘤变(CIN)转变为高级别CIN的标志性特征。因此,导致局部晚期宫颈转移病变的早期事件需要更深入地了解其潜在机制。近期线索表明肿瘤来源的外泌体在改变宫颈癌中内皮细胞功能方面发挥作用,这需要进一步研究。
使用管腔形成和伤口愈合试验评估从宫颈癌细胞系中分离出的外泌体对人脐静脉内皮细胞(HUVEC)的血管生成作用。通过PKH-67标记随后进行荧光显微镜观察来监测HUVEC细胞对外泌体的摄取。通过免疫印迹法检测HUVEC中Hh-GLI信号通路成分PTCH1和GLI1的变化。通过RT-PCR检测外泌体处理的HUVEC和外泌体RNA中血管内皮生长因子VEGF-A、VEGF-B、VEGFR2以及血管生成素-1、血管生成素-2、骨桥蛋白等血管生成相关转录本的变化。
在用源自不同宫颈癌细胞系的外泌体处理的HUVEC中观察到管腔形成增强,节点和分支数量增加。HPV阳性(SiHa和HeLa)细胞的外泌体血管生成作用更强。外泌体处理的HUVEC迁移率增加。发现PKH-67标记的外泌体被HUVEC内化。在外泌体处理的内皮细胞中检测到高水平的PTCH1蛋白。随后的RT-PCR分析显示Hh-GLI下游靶基因VEGF-A、VEGFR2、血管生成素-2的转录本增加,而VEGF-B和血管生成素-1的表达降低,提示Hh-GLI信号通路活跃。在用HPV阳性细胞的外泌体处理的HUVEC中这些效应更明显。然而,这些效应独立于肿瘤来源的VEGF-A,因为外泌体货物缺乏VEGF-A转录本或蛋白质。
总体而言,数据表明宫颈癌外泌体通过上调Hh-GLI信号通路促进内皮细胞的促血管生成反应,并调节下游血管生成相关靶基因。该研究提供了一种新的外泌体介导机制,可能有利于宫颈血管生成,从而将外泌体确定为针对局部晚期转移性宫颈病变的潜在药理学靶点。